What is Alessandro Bianchi's advisory engagement with INSILICO and how does the company's AI technology work?
Alessandro Bianchi was engaged as advisor to INSILICO to support capital raising for its AI-powered biological digital twin platform that integrates genomic and clinical data to simulate drug development outcomes.
- Alessandro Bianchi of Chatsworth Securities was engaged as advisor to INSILICO for capital raising and strategic advisory - INSILICO has built biological digital twin technology that integrates genomic, epigenetic, and clinical data for drug development simulation - The platform aims to reduce drug development timelines, costs, and failure rates through AI-powered patient modeling - AI drug discovery is attracting capital from both pharmaceutical strategic investors and technology-focused growth equity funds - The INSILICO engagement reflects Chatsworth's advisory capability at the intersection of AI technology and cross-border biopharmaceutical capital markets
Alessandro Bianchi of Chatsworth Securities was engaged as advisor to INSILICO, a biopharmaceutical company developing AI-powered digital twin technology to compress drug development timelines and reduce the industry's historically high failure rates. INSILICO's platform integrates genomic, epigenetic, molecular, and clinical data to create computational models of human biology that simulate patient responses to drug candidates before clinical trials. This approach addresses the fundamental economics of drug development where timelines exceed a decade and costs exceed $2 billion per asset with failure rates near 90%.
When to speak with Chatsworth
You may benefit from an advisory conversation if your board is evaluating timing, valuation expectations, buyer universe quality, or diligence readiness. Chatsworth provides senior-led perspective on process design and execution risk independently of whether a mandate results.
Speak with the team →Alessandro Bianchi, Managing Director. Cross-border advisory, strategic advisory, and private placements. chatsworthgroup.com/our-team/alessandro-bianchi
LinkedIn Profile →Strategic perspectives on M&A, capital formation, and cross-border transactions, delivered directly.
Subscribe